CSOP Hang Seng Biotech ETF (03174.HK) rose 3.18%, with the latest price at HKD 3.632
As of 09:44 on April 28, according to Newtimespace, the CSOP Hang Seng Biotech ETF (03174.HK) rose 3.18%, with the latest price at HKD 3.632, a high of HKD 3.632, a low of HKD 3.520, an average price of HKD 3.602, assets under management of approximately HKD 891 million, a latest net asset value of HKD 3.518, and a premium of 0.07%.
The CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index, which consists of listed companies in biotech, pharmaceuticals, and healthcare sectors in Hong Kong, reflecting the overall performance of Hong Kong's biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Mabwell(02493.HK) Elects Dr. Gui Xun as Employee Representative Director
- Ruixin International Group (00724.HK): Delisting to Take Effect from June 23
- Far East Horizon (03360.HK): Update of US$4 Billion Medium-Term Note and Perpetual Securities Programme
- Asia Allied Infrastructure (00711.HK): Positive Profit Alert, Expected Annual Profit of Not Less Than HK$120 Million
- Huaneng Power International, Inc. (00902.HK): Completes Issuance of RMB 2 Billion Medium-Term Notes with a Coupon Rate of 1.70%
